FEB 06, 2014 1:00 PM PST

Perioperative analgesia

C.E. Credits: CE
Speaker
  • Professor, Anesthesiologist, University Complutense, Spain
    Biography
      Ignacio Alvarez Gomez de Segura teaches and practices anaesthesiology since 2005 at the Veterinary School of Complutense University of Madrid (Spain), where he graduated in 1986. He holds the ECVAA and ECLAM diplomate status. Previously he worked as head of the Animal Facility at the Experimental Surgery Department of of the (human) Hospital La Paz, also in Madrid (1988-2005).

    Abstract

    perioperative analgesia aims to minimize, or even eliminate pain during a surgical procedure. Currently this approach is rarely performed using a single analgesic drug and more commonly different types of analgesic drugs, such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs), are combined. This approach is known as multimodal or polymodal analgesia and also includes other analgesic drugs and techniques such as alpha-2 adrenergic receptor agonists, ketamine, or loco-regional analgesic techniques. Another approach is the anticipation to perioperative pain by administering analgesic drugs before surgical injury occurs and thus preventing the animal suffering from pain. This approach is known as preemptive analgesia and may reduce pain not only intraoperatively but also postoperatively. Other relevant aspects include the expected pain intensity, which allows us to select the appropriate drugs or drug combinations. The duration of analgesic therapy should also conform to the expected duration of pain so as to provide the necessary coverage postoperatively. Fortunately, there are on the market analgesic formulations with an effect typically lasting 24 hours with some of them providing analgesia up to 4 days following a single drug administration. Despite these advances, a good postoperative analgesia can only be obtained with an appropriate pain assessment system that would allow changes to the analgesic regimen in order to limit or prevent pain effectively.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    Loading Comments...
    Show Resources
    Attendees
    • See more